Production of Anti-Viral drug Remdesivir will be doubled to nearly 3 lakh vials per day in the next 15 days. Informing of the decision, Minister of State for Chemical & Fertilizer Mansukh Mandaviya said that the Centre is committed to ensure affordable availability of the drug. Remdesivir has shown to have effective results in better recovery of critically ill and hospitalised COVID patients. Mr. Mandaviya said currently 20 manufacturing plants are engaged in the country in manufacturing the anti-viral drug.
He added that another 20 manufacturing sites have already been granted government’s approval and they would soon add to the existing production capacity of 1 lakh 50 thousand vials per day. The minister asserted that due to centre’s active intervention, the major pharma companies have significantly reduced the prices of their Remdesivir brands.
Support Ethical Journalism. Support The Dispatch
The Dispatch is a sincere effort in ethical journalism. Truth, Accuracy, Independence, Fairness, Impartiality, Humanity and Accountability are key elements of our editorial policy. But we are still not able to generate great stories, because we don’t have adequate resources. As more and more media falls into corporate and political control, informed citizens across the world are funding independent journalism initiatives. Here is your chance to support your local media startup and help independent journalism survive. Click the link below to make a payment of your choice and be a stakeholder in public spirited journalism